Can YKL-40 be used as a biomarker for interstitial lung disease?: A systematic review and meta-analysis

BACKGROUND: Interstitial lung disease (ILD) has a poor prognosis and lacks specific biomarkers for early diagnosis, assessment of disease severity, and prognosis. YKL-40 levels were found to be elevated in patients with ILD, but these results are inconsistent. Therefore, we conducted a systematic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Xiang, Ma, Yao, Liu, Tao, Li, Zhenzhen, Liu, Sitong, Wu, Guihui, Fan, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083999/
https://www.ncbi.nlm.nih.gov/pubmed/33907118
http://dx.doi.org/10.1097/MD.0000000000025631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083999/
https://www.ncbi.nlm.nih.gov/pubmed/33907118
http://dx.doi.org/10.1097/MD.0000000000025631

Ejemplares similares